BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

282 related articles for article (PubMed ID: 21292164)

  • 1. Nascent peptide in the ribosome exit tunnel affects functional properties of the A-site of the peptidyl transferase center.
    Ramu H; Vázquez-Laslop N; Klepacki D; Dai Q; Piccirilli J; Micura R; Mankin AS
    Mol Cell; 2011 Feb; 41(3):321-30. PubMed ID: 21292164
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Molecular mechanism of drug-dependent ribosome stalling.
    Vazquez-Laslop N; Thum C; Mankin AS
    Mol Cell; 2008 Apr; 30(2):190-202. PubMed ID: 18439898
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Programmed drug-dependent ribosome stalling.
    Ramu H; Mankin A; Vazquez-Laslop N
    Mol Microbiol; 2009 Feb; 71(4):811-24. PubMed ID: 19170872
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Cis-acting resistance peptides reveal dual ribosome inhibitory action of the macrolide josamycin.
    Lovmar M; Vimberg V; Lukk E; Nilsson K; Tenson T; Ehrenberg M
    Biochimie; 2009 Aug; 91(8):989-95. PubMed ID: 19463886
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Statics of the ribosomal exit tunnel: implications for cotranslational peptide folding, elongation regulation, and antibiotics binding.
    Fulle S; Gohlke H
    J Mol Biol; 2009 Mar; 387(2):502-17. PubMed ID: 19356596
    [TBL] [Abstract][Full Text] [Related]  

  • 6. On the use of the antibiotic chloramphenicol to target polypeptide chain mimics to the ribosomal exit tunnel.
    Mamos P; Krokidis MG; Papadas A; Karahalios P; Starosta AL; Wilson DN; Kalpaxis DL; Dinos GP
    Biochimie; 2013 Sep; 95(9):1765-72. PubMed ID: 23770443
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Nascent polypeptide sequences that influence ribosome function.
    Cruz-Vera LR; Sachs MS; Squires CL; Yanofsky C
    Curr Opin Microbiol; 2011 Apr; 14(2):160-6. PubMed ID: 21342782
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Structural basis for translational stalling by human cytomegalovirus and fungal arginine attenuator peptide.
    Bhushan S; Meyer H; Starosta AL; Becker T; Mielke T; Berninghausen O; Sattler M; Wilson DN; Beckmann R
    Mol Cell; 2010 Oct; 40(1):138-46. PubMed ID: 20932481
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A model for the role of isomerization in nascent peptide movement through the ribosomal tunnel.
    Agmon IC
    FASEB J; 2012 Jun; 26(6):2277-82. PubMed ID: 22389440
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Symmetry at the active site of the ribosome: structural and functional implications.
    Agmon I; Bashan A; Zarivach R; Yonath A
    Biol Chem; 2005 Sep; 386(9):833-44. PubMed ID: 16164408
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Changes produced by bound tryptophan in the ribosome peptidyl transferase center in response to TnaC, a nascent leader peptide.
    Cruz-Vera LR; Gong M; Yanofsky C
    Proc Natl Acad Sci U S A; 2006 Mar; 103(10):3598-603. PubMed ID: 16505360
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Multisite ribosomal stalling: a unique mode of regulatory nascent chain action revealed for MifM.
    Chiba S; Ito K
    Mol Cell; 2012 Sep; 47(6):863-72. PubMed ID: 22864117
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Signal sequence-independent membrane targeting of ribosomes containing short nascent peptides within the exit tunnel.
    Bornemann T; Jöckel J; Rodnina MV; Wintermeyer W
    Nat Struct Mol Biol; 2008 May; 15(5):494-9. PubMed ID: 18391966
    [TBL] [Abstract][Full Text] [Related]  

  • 14. RMF inactivates ribosomes by covering the peptidyl transferase centre and entrance of peptide exit tunnel.
    Yoshida H; Yamamoto H; Uchiumi T; Wada A
    Genes Cells; 2004 Apr; 9(4):271-8. PubMed ID: 15066119
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Ribosomal crystallography: peptide bond formation and its inhibition.
    Bashan A; Zarivach R; Schluenzen F; Agmon I; Harms J; Auerbach T; Baram D; Berisio R; Bartels H; Hansen HA; Fucini P; Wilson D; Peretz M; Kessler M; Yonath A
    Biopolymers; 2003 Sep; 70(1):19-41. PubMed ID: 12925991
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Interplay between the ribosomal tunnel, nascent chain, and macrolides influences drug inhibition.
    Starosta AL; Karpenko VV; Shishkina AV; Mikolajka A; Sumbatyan NV; Schluenzen F; Korshunova GA; Bogdanov AA; Wilson DN
    Chem Biol; 2010 May; 17(5):504-14. PubMed ID: 20534348
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Arrest peptides: cis-acting modulators of translation.
    Ito K; Chiba S
    Annu Rev Biochem; 2013; 82():171-202. PubMed ID: 23746254
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The key function of a conserved and modified rRNA residue in the ribosomal response to the nascent peptide.
    Vázquez-Laslop N; Ramu H; Klepacki D; Kannan K; Mankin AS
    EMBO J; 2010 Sep; 29(18):3108-17. PubMed ID: 20676057
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Properties of intraribosomal part of nascent polypeptide.
    Kolb VA
    Biochemistry (Mosc); 2010 Dec; 75(13):1517-27. PubMed ID: 21417992
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Ribosomal tolerance and peptide bond formation.
    Yonath A
    Biol Chem; 2003; 384(10-11):1411-9. PubMed ID: 14669983
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.